DUSP22 promotes senescence of HS-1 skin cancer cells through triggering MAPK signaling pathway.

Zhao XD, Huang C, Wang RX, Wang SA

Open source

DOI
10.26355/eurrev_201811_16406
Published
2018 Nov
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201811_16406,
  title = {DUSP22 promotes senescence of HS-1 skin cancer cells through triggering MAPK signaling pathway.},
  author = {Zhao XD and Huang C and Wang RX and Wang SA},
  year = {2018},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201811_16406},
  url = {https://doi.org/10.26355/eurrev_201811_16406}
}

RIS

TY  - JOUR
TI  - DUSP22 promotes senescence of HS-1 skin cancer cells through triggering MAPK signaling pathway.
AU  - Zhao XD
AU  - Huang C
AU  - Wang RX
AU  - Wang SA
PY  - 2018
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201811_16406
UR  - https://doi.org/10.26355/eurrev_201811_16406
ER  - 

APA

XD, Z., C, H., RX, W., & SA, W. (2018). DUSP22 promotes senescence of HS-1 skin cancer cells through triggering MAPK signaling pathway.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201811_16406

Source records